Seyler, T. M., Smith, B. P., Marker, D. R., Ma, J., Shen, J., Smith, T. L., … Koman, L. A. (2008). Botulinum neurotoxin as a therapeutic modality in orthopaedic surgery: more than twenty years of experience. J Bone Joint Surg Am, 90 Suppl 4, 133–145. https://doi.org/10.2106/JBJS.H.00901

Seyler, Thorsten M., Beth P. Smith, David R. Marker, Jianjun Ma, Jian Shen, Tom L. Smith, Michael A. Mont, Kat Kolaski, and L Andrew Koman. “Botulinum neurotoxin as a therapeutic modality in orthopaedic surgery: more than twenty years of experience.” J Bone Joint Surg Am 90 Suppl 4 (November 2008): 133–45. https://doi.org/10.2106/JBJS.H.00901.

Seyler TM, Smith BP, Marker DR, Ma J, Shen J, Smith TL, et al. Botulinum neurotoxin as a therapeutic modality in orthopaedic surgery: more than twenty years of experience. J Bone Joint Surg Am. 2008 Nov;90 Suppl 4:133–45.

Seyler, Thorsten M., et al. “Botulinum neurotoxin as a therapeutic modality in orthopaedic surgery: more than twenty years of experience.” J Bone Joint Surg Am, vol. 90 Suppl 4, Nov. 2008, pp. 133–45. Pubmed, doi:10.2106/JBJS.H.00901.

Seyler TM, Smith BP, Marker DR, Ma J, Shen J, Smith TL, Mont MA, Kolaski K, Koman LA. Botulinum neurotoxin as a therapeutic modality in orthopaedic surgery: more than twenty years of experience. J Bone Joint Surg Am. 2008 Nov;90 Suppl 4:133–145.